Investor Update

Basel, 17 September 2015

Chugai: Avastin Application for Approval of Additional Indication of Recurrent / Advanced Cervical Cancer in Japan

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.